Oncology

HER2+ Breast Cancer

Advertisment
Increasing Survival in Patients With HER2+ Breast Cancer
HER2+ Breast Cancer

Increasing Survival in Patients With HER2+ Breast Cancer

expert roundtables
By Ian Krop, MD, PhD; Joseph A. Sparano, MD, FACP; Sara M. Tolaney, MD, MPH
Recent Developments in HER2-Targeted Therapy
HER2+ Breast Cancer

Recent Developments in HER2-Targeted Therapy

clinical topic updates
By Ian Krop, MD, PhD
Identifying Candidates for Neoadjuvant or Adjuvant Anti-HER2 Therapy
HER2+ Breast Cancer

Identifying Candidates for Neoadjuvant or Adjuvant Anti-HER2 Therapy

patient care perspectives
By Sara M. Tolaney, MD, MPH
Current and Future Roles of Next-Generation Sequencing in HER2+ Breast Cancer
HER2+ Breast Cancer

Current and Future Roles of Next-Generation Sequencing in HER2+ Breast Cancer

clinical topic updates
By Joseph A. Sparano, MD, FACP
Early HER2+ Breast Cancer: How Should Pathological Responses to Neoadjuvant Therapy at the Time of Surgery Guide Decisions About Adjuvant Treatment?
HER2+ Breast Cancer

Early HER2+ Breast Cancer: How Should Pathological Responses to Neoadjuvant Therapy at the Time of Surgery Guide Decisions About Adjuvant Treatment?

patient care perspectives
By Sara M. Tolaney, MD, MPH
Load More   

Experts in HER2+ Breast Cancer

+0

Meet the Experts   

Advertisment